← 產業報告目錄
Recombinant Chemicals Market Size, Share & Trends Analysis Report By Product Type (Recombinant Proteins, Recombinant DNAs, Recombinant Peptides, Others), By Technology (Microbial Expression Systems, Mammalian Cell Expression Systems, Yeast Expression Systems, Insect Cell Expression Systems, Cell-free Expression Systems), By Application, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-04頁數 170報告編號 INSIGHTACE-9ed330b1af
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 2.87 billion, the global Recombinant Chemicals Market is expected to advance to USD 4.67 billion by 2031, demonstrating a CAGR of 6.4% during the 2024–2031 forecast window.
The Recombinant Chemicals sector involves products or substances that are generated using recombinant dna technology, which involves combining dna from multiple sources to create novel genetic combinations. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is propelled by escalating interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Recombinant Chemicals Market Snapshot
Chapter 4. Global Recombinant Chemicals Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Product Type:
5.2.1. Recombinant Proteins
5.2.2. Recombinant DNAs
5.2.3. Recombinant Peptides
5.2.4. Others
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. By Technology & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Technology:
6.2.1. Microbial Expression Systems
6.2.2. Mammalian Cell Expression Systems
6.2.3. Yeast Expression Systems
6.2.4. Insect Cell Expression Systems
6.2.5. Cell-free Expression Systems
Chapter 7. Market Segmentation 3: By Application Estimates & Trend Analysis
7.1. By Application & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:
7.2.1. Drug Development
7.2.2. Vaccine Production
7.2.3. Therapeutics
7.2.4. Cell Line Development
7.2.5. Agriculture
7.2.6. Food and Beverage
7.2.7. Others
Chapter 8. Recombinant Chemicals Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.1.2. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.1.3. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.4. North America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031.
8.2. Europe
8.2.1. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.2.2. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.2.3. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.4. Europe Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.3.2. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.3.3. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.4. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Asia Pacific Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.4.2. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.4.3. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.4. Latin America Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031.
8.5. Middle East & Africa
8.5.1. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2024-2031
8.5.2. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2024-2031
8.5.3. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.4. Middle East & Africa Recombinant Chemicals Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Genentech, Inc.
9.2.2. Amgen Inc.
9.2.3. Biogen
9.2.4. Pfizer, Inc.
9.2.5. Novartis AG
9.2.6. Merck & Co.
9.2.7. Sanofi
9.2.8. F. Hoffmann-La Roche AG
9.2.9. Johnson & Johnson Services, Inc.
9.2.10. Bayer AG
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們